Form C-AR — iMetabolic Biopharma Corporation
0001665160-23-000924 · filed Apr 27, 2023
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1957114
- Entity
- Corporation
- Jurisdiction
- NV
- Address
- 275 N Gateway Dr, Suite 104
Phoenix, AZ 85034 - Phone
- —
Most recent fiscal year financials
- Total assets
- $4,601
- Cash
- —
- Short-term debt
- —
- Long-term debt
- $161,025
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-94,513
View the original filing on SEC EDGAR ↗